Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Staffurth

Showing results (31-40 of 84) with videos related to

Pageof 9
Sort By:
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|June 2, 2019
Machine-learned target volume delineation of <sup>18</sup>F-FDG PET images after one cycle of induction chemotherapyCraig Parkinson, Mererid Evans, Teresa Guerrero-Urbano, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2014
Enhancement of T cell responses as a result of synergy between lower doses of radiation and T cell stimulationLisa K Spary, Saly Al-Taei, Josephine Salimu, et al.
Clinical and Translational Radiation Oncology|September 30, 2020
PIVOTALboost: A phase III randomised controlled trial of prostate and pelvis versus prostate alone radiotherapy with or without prostate boost (CRUK/16/018)Isabel Syndikus, Clare Cruickshank, John Staffurth, et al.
International Journal of Radiation Oncology, Biology, Physics|June 6, 2006
A comparison of CT- and ultrasound-based imaging to localize the prostate for external beam radiotherapyHelen A McNair, Stephen A Mangar, Jerome Coffey, et al.
Trials|October 23, 2014
Palliative radiotherapy in addition to self-expanding metal stent for improving dysphagia and survival in advanced oesophageal cancer (ROCS: Radiotherapy after Oesophageal Cancer Stenting): study protocol for a randomized controlled trialDouglas Adamson, Jane Blazeby, Annmarie Nelson, et al.
BMJ Open|October 5, 2016
Improving the well-being of men by Evaluating and Addressing the Gastrointestinal Late Effects (EAGLE) of radical treatment for prostate cancer: study protocol for a mixed-method implementation projectSophia Taylor, Weyinmi Demeyin, Ann Muls, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 19, 2019
Evaluating the application of Pareto navigation guided automated radiotherapy treatment planning to prostate cancerPhilip A Wheeler, Michael Chu, Rosemary Holmes, et al.
Contemporary Clinical Trials|April 18, 2020
Comparative Healthcare Research Outcomes of Novel Surgery in prostate cancer (IP4-CHRONOS): A prospective, multi-centre therapeutic phase II parallel Randomised Control TrialDeepika Reddy, Taimur T Shah, Tim Dudderidge, et al.
Radiation Oncology (London, England)|April 8, 2024
Multi-institutional evaluation of a Pareto navigation guided automated radiotherapy planning solution for prostate cancerPhilip A Wheeler, Nicholas S West, Richard Powis, et al.
European Journal of Cancer (Oxford, England : 1990)|August 27, 2013
Effect of abiraterone acetate treatment on the quality of life of patients with metastatic castration-resistant prostate cancer after failure of docetaxel chemotherapyStephen Harland, John Staffurth, Arturo Molina, et al.
Pageof 9

Showing results (31-40 of 84) with videos related to

Sort By:
Pageof 9
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|June 2, 2019
Machine-learned target volume delineation of <sup>18</sup>F-FDG PET images after one cycle of induction chemotherapyCraig Parkinson, Mererid Evans, Teresa Guerrero-Urbano, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2014
Enhancement of T cell responses as a result of synergy between lower doses of radiation and T cell stimulationLisa K Spary, Saly Al-Taei, Josephine Salimu, et al.
Clinical and Translational Radiation Oncology|September 30, 2020
PIVOTALboost: A phase III randomised controlled trial of prostate and pelvis versus prostate alone radiotherapy with or without prostate boost (CRUK/16/018)Isabel Syndikus, Clare Cruickshank, John Staffurth, et al.
International Journal of Radiation Oncology, Biology, Physics|June 6, 2006
A comparison of CT- and ultrasound-based imaging to localize the prostate for external beam radiotherapyHelen A McNair, Stephen A Mangar, Jerome Coffey, et al.
Trials|October 23, 2014
Palliative radiotherapy in addition to self-expanding metal stent for improving dysphagia and survival in advanced oesophageal cancer (ROCS: Radiotherapy after Oesophageal Cancer Stenting): study protocol for a randomized controlled trialDouglas Adamson, Jane Blazeby, Annmarie Nelson, et al.
BMJ Open|October 5, 2016
Improving the well-being of men by Evaluating and Addressing the Gastrointestinal Late Effects (EAGLE) of radical treatment for prostate cancer: study protocol for a mixed-method implementation projectSophia Taylor, Weyinmi Demeyin, Ann Muls, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 19, 2019
Evaluating the application of Pareto navigation guided automated radiotherapy treatment planning to prostate cancerPhilip A Wheeler, Michael Chu, Rosemary Holmes, et al.
Contemporary Clinical Trials|April 18, 2020
Comparative Healthcare Research Outcomes of Novel Surgery in prostate cancer (IP4-CHRONOS): A prospective, multi-centre therapeutic phase II parallel Randomised Control TrialDeepika Reddy, Taimur T Shah, Tim Dudderidge, et al.
Radiation Oncology (London, England)|April 8, 2024
Multi-institutional evaluation of a Pareto navigation guided automated radiotherapy planning solution for prostate cancerPhilip A Wheeler, Nicholas S West, Richard Powis, et al.
European Journal of Cancer (Oxford, England : 1990)|August 27, 2013
Effect of abiraterone acetate treatment on the quality of life of patients with metastatic castration-resistant prostate cancer after failure of docetaxel chemotherapyStephen Harland, John Staffurth, Arturo Molina, et al.
Pageof 9